體學定序市場規模、佔有率和成長分析：按體學類型、技術、應用、最終用戶、工作流程、產品類型和地區分類 - 產業預測，2026-2033年

2024 年全球體學定序市場價值 186 億美元，預計到 2025 年將成長至 213.3 億美元，到 2033 年將成長至 639.2 億美元，在預測期（2026-2033 年）內複合年成長率為 14.7%。

全球體學定序市場在解碼涵蓋DNA、RNA、蛋白質、代謝物等分子數據方面發揮著至關重要的作用，為研發、診斷和藥物開發提供關鍵資訊。它在精準醫療、先進農業和環境評估領域也扮演著舉足輕重的角色。該市場經歷了顯著的發展，從早期的桑格定序發展到高通量技術和單細胞分析解決方案。隨著監管支持推動個人化醫療的轉型，保險公司越來越要求對標靶治療進行分子層面的檢驗，而組學定序市場的重要性也日益凸顯。同時，人工智慧驅動的自動化正在透過簡化樣本定序、最佳化檢體流程和最大限度地減少錯誤來變革市場，從而擴大應用範圍並降低成本。這些技術進步，加上監管支持，正在推動腫瘤學和農業領域的應用，進一步促進市場成長。

全球體學定序市場促進因素

全球體學定序市場的主要驅動力之一是對個人化醫療日益成長的需求。隨著醫療保健轉向更個人化的治療方案，全面基因組資訊對於了解患者的特定病情並據此最佳化治療至關重要。定序技術的進步顯著降低了成本和處理時間，使研究人員和臨床醫生更容易獲得基因組數據。此外，遺傳疾病盛行率的上升以及對疾病早期檢測的日益重視，正在推動對體學研究的投資，加強藥物研發，並促進定序市場的整體成長。

全球體學定序市場面臨的限制因素

全球體學定序市場的主要限制因素之一是定序技術及相關生物資訊學服務的高成本。這些成本會限制小規模研究機構和發展中地區的取得途徑，從而阻礙市場成長。此外，管理和解讀定序過程中產生的大量資料十分複雜，需要專業知識，而這種專業知識並非所有機構都能輕易取得。與基因資料處理相關的倫理和監管問題也會阻礙研究活動，減緩定序技術在各種應用中的普及，並影響整體市場擴張。

全球體學定序市場趨勢

全球體學定序市場正經歷著向個人化醫療轉型的重要趨勢，醫療服務提供者擴大利用體學定序，根據基因譜制定個人化治療方案。這一成長的驅動力源於臨床醫生對可操作生物標記的日益重視，以及對滿足患者期望的精準干預措施的日益關注。此外，以結果為導向的新型醫保模式的演變也進一步推動了市場成長。製藥公司也在藥物研發的早期階段整合定序數據，從而縮短回饋週期，並縮短從標靶識別到患者入組臨床試驗的時間。這種協同效應為全球定序服務供應商創造了持續成長的機會。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球體學定序市場規模：依體學類型分類

• 基因組學
• 轉錄組學
• 表觀基因
• 總體基因體學

全球體學定序市場規模：依技術分類

• 次世代定序
• 第三代定序

全球體學定序市場規模：按應用領域分類

• 臨床診斷
• 藥物發現
• 農業研究
• 其他

全球體學定序市場規模：依最終用戶分類

• 研究機構
• 製藥和生物技術公司
• 臨床實驗室
• 其他

全球體學定序市場規模：依工作流程分類

• 樣品製備
• 定序
• 數據分析

全球體學定序市場規模：依產品類型分類

• 裝置
• 消耗品
• 軟體
• 服務

全球體學定序市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Illumina, Inc.
• PacBio
• Oxford Nanopore Technologies plc
• Thermo Fisher Scientific Inc.
• BGI Genomics Co., Ltd.
• QIAGEN NV
• Roche Holding AG
• Agilent Technologies, Inc.
• Element Biosciences
• Singular Genomics Systems, Inc.
• Complete Genomics
• Standard BioTools Inc.
• Azenta, Inc.
• Integrated DNA Technologies, Inc.
• Eurofins Scientific SE
• Novogene Co., Ltd.
• Genewiz
• Macrogen, Inc.
• SeqMatic LLC
• GeneDx Holdings Corp.

結論與建議

Global Omics Sequencing Market size was valued at USD 18.6 Billion in 2024 and is poised to grow from USD 21.33 Billion in 2025 to USD 63.92 Billion by 2033, growing at a CAGR of 14.7% during the forecast period (2026-2033).

The global omics sequencing market is pivotal in decoding molecular data encompassing DNA, RNA, proteins, and metabolites, providing vital insights for research, diagnostics, and drug development. It plays a crucial role in enabling precision medicine, agricultural enhancements, and environmental assessments. The market has evolved significantly, advancing from initial Sanger sequencing methods to high-throughput technologies and single-cell solutions. The drive towards personalized therapeutics, supported by regulatory backing, has intensified the market's relevance, as insurers increasingly demand molecular validation for targeted treatments. Concurrently, AI-driven automation is reshaping the landscape by enhancing sample preparation, optimizing sequencing workflows, and minimizing errors, thereby increasing access and reducing costs. This interplay of technological advancement and regulatory endorsement propels broader adoption across oncology and agricultural sectors, fostering continuous market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Omics Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Omics Sequencing Market Segments Analysis

Global omics sequencing market is segmented by omics type, technology, application, end user, workflow, product type and region. Based on omics type, the market is segmented into Genomics, Transcriptomics, Epigenomics and Metagenomics. Based on technology, the market is segmented into Next-Generation Sequencing and Third-Generation Sequencing. Based on application, the market is segmented into Clinical Diagnostics, Drug Discovery, Agricultural Research and Others. Based on end user, the market is segmented into Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical Laboratories and Others. Based on workflow, the market is segmented into Sample Preparation, Sequencing and Data Analysis. Based on product type, the market is segmented into Instruments, Consumables, Software and Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Omics Sequencing Market

One of the key market drivers for the global omics sequencing market is the increasing demand for personalized medicine. As healthcare shifts towards more individualized treatment approaches, the need for comprehensive genomic information becomes paramount in understanding patient-specific conditions and tailoring therapies accordingly. Advances in sequencing technologies have significantly reduced costs and improved turnaround times, making genomic data more accessible to researchers and clinicians. Additionally, the rising prevalence of genetic disorders and the growing emphasis on early disease detection are propelling investment in omic studies, enhancing drug development, and boosting the overall growth of the sequencing market.

Restraints in the Global Omics Sequencing Market

One of the key market restraints for the global omics sequencing market is the high cost associated with sequencing technologies and associated bioinformatics services. These expenses can limit access for smaller research institutions and developing regions, thus restricting market growth. Additionally, the complexity of managing and interpreting vast amounts of data generated from sequencing processes requires specialized expertise, which may not be readily available in all settings. Furthermore, ethical and regulatory concerns surrounding genetic data handling can hinder research initiatives and slow down the adoption of sequencing technologies across various applications, impacting overall market expansion.

Market Trends of the Global Omics Sequencing Market

The Global Omics Sequencing market is witnessing a significant trend toward personalized medicine, as healthcare providers increasingly utilize omics sequencing to customize treatments based on genetic profiles. This growing adoption is fueled by enhanced clinician awareness of actionable biomarkers and an amplified emphasis on precision interventions meeting patient expectations. Additionally, evolving reimbursement models that prioritize outcome-based care further catalyze market expansion. Pharmaceutical companies are also integrating sequencing data earlier in the drug development process, fostering tighter feedback loops that reduce the time from target identification to clinical trial enrollment. This synergy is resulting in sustained growth opportunities for sequencing service providers across global markets.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Omics Sequencing Market Size by Omics Type & CAGR (2026-2033)

• Market Overview
• Genomics
• Transcriptomics
• Epigenomics
• Metagenomics

Global Omics Sequencing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Next-Generation Sequencing
• Third-Generation Sequencing

Global Omics Sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics
• Drug Discovery
• Agricultural Research
• Others

Global Omics Sequencing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Laboratories
• Others

Global Omics Sequencing Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Sample Preparation
• Sequencing
• Data Analysis

Global Omics Sequencing Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Instruments
• Consumables
• Software
• Services

Global Omics Sequencing Market Size & CAGR (2026-2033)

• North America (Omics Type, Technology, Application, End User, Workflow, Product Type)
  • US
  • Canada
• Europe (Omics Type, Technology, Application, End User, Workflow, Product Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Omics Type, Technology, Application, End User, Workflow, Product Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Omics Type, Technology, Application, End User, Workflow, Product Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Omics Type, Technology, Application, End User, Workflow, Product Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PacBio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Element Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Singular Genomics Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Complete Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeqMatic LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneDx Holdings Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations